• Sunday, May 29, 2022


Unilever Appears As Top Bidder For GSK’s Horlicks Business In India: Sources

If two parties manage to reach a deal then, the acquisition is likely to expand Uniliver’s business and to grab a major market share in India where climbing population and household income are very likely to yield attractive return for long term investments (Photo: Igor Golovniov/SOPA Images/LightRocket via Getty Images).

By: Radhakrishna N S

Anglo-Dutch business giant, Unilever PLC has emerged as a leading bidder in the tough competition for Indian Horlicks nutrition business owned by GlaxoSmithKline (GSK), media reports said on Wednesday (28). Unilever and GSK, which has 72.5 per cent share in Indian business GlaxoSmithKline Consumer Healthcare Ltd, are in exclusive discussions, according to the Indian media reports on Tuesday (27). GSK’s brands, including well known malt-based drinks Horlicks and Boost, is likely to fetch less than £3.13 billion ($4bn), according to the sources quoted by Reuters in its news report. Earlier, separate sources had informed that the two parties agree on…

You do not have access to this content. You need to subscribe.

Eastern Eye

Related Stories

Eastern Eye


Mrunal Thakur on Dhamaka, experience of working with Kartik Aaryan,…
Nushrratt Bharuccha on Chhorii, pressure of comparison with Lapachhapi, upcoming…
Abhimanyu Dassani on Meenakshi Sundareshwar, how his mom Bhagyashree reacted…